MRA General RFP
MRA 2018-2019 Request for Proposals - Now Closed
The Melanoma Research Alliance (MRA) announces a Request for Proposals (RFP) soliciting high-impact pre-clinical, translational, and early clinical research from scientists and clinicians around the world. The RFP calls for ideas that have the potential to lead to near-term clinical application in melanoma prevention, detection, diagnosis, staging, and treatment.
Proposals will be accepted for Established Investigator Awards, Pilot Awards, and Young Investigator Awards. Please note that the following Special Opportunities are available:
- Special Opportunity MRA Young Investigator and MRA Established Investigator Awards for Artificial Intelligence Applied to Melanoma
- Special Opportunity MRA Young Investigator Award and Established Investigator Award in Dermatology
- Special Opportunity Young Investigator Awards in Immunotherapy
- Special Opportunity ASTRO-MRA Early Career Investigator Award in Radiation Oncology
- Special Opportunity SITC-MRA Young Investigator Award in Immune-Related Adverse Events Associated with Immunotherapy
November 2, 2018: Deadline for all Established Investigator, Pilot, and Young Investigator Award full proposal applications.
November 9, 2018: Deadline for ASTRO-MRA Early Career Investigator full proposal applications.
Full descriptions of each award opportunity offered, including all Special Opportunity Awards, as well as eligibility criteria and instructions can be found in the MRA 2018-2019 RFP document:
Tasheema Prince, MRA Scientific Program Manager
Melanoma is a leading cause of new cancers, and more effective options for patients and those at risk are urgently needed. Recent scientific and clinical advances have provided new hope, but much work remains to be done to end suffering and death from melanoma.